One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses

SARS-CoV-2 has caused over 100,000,000 cases and almost 2,500,000 deaths globally. Comprehensive assessment of the multifaceted antiviral Ab response is critical for diagnosis, differentiation of severity, and characterization of long-term immunity, especially as COVID-19 vaccines become available....

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Natalie S., Nguyen, Doan C., Kuruvilla, Merin E., Morrison-Porter, Andrea, Anam, Fabliha, Cashman, Kevin S., Ramonell, Richard P., Kyu, Shuya, Saini, Ankur Singh, Cabrera-Mora, Monica, Derrico, Andrew, Alter, David, Roback, John D., Horwath, Michael, O’Keefe, James B., Wu, Henry M., Wong, An-Kwok Ian, Dretler, Alexandra W., Gripaldo, Ria, Lane, Andrea N., Wu, Hao, Chu, Helen Y., Lee, Saeyun, Hernandez, Mindy, Engineer, Vanessa, Varghese, John, Patel, Rahul, Jalal, Anum, French, Victoria, Guysenov, Ilya, Lane, Christopher E., Mengistsu, Tesfaye, Normile, Katherine Elizabeth, Mnzava, Onike, Le, Sang, Sanz, Ignacio, Daiss, John L., Lee, F. Eun-Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190970/
https://www.ncbi.nlm.nih.gov/pubmed/34001652
http://dx.doi.org/10.4049/immunohorizons.2100011

Ejemplares similares

Ejemplares similares